Category: Crypto Hub

Posted on by — Leave a comment

Five herbal medicines potent against tick-borne disease babesiosis in lab – Medical Xpress

             Sign in with                 <a href="https://sciencex.com/profile/sm-login-redirect/fb/" class="login-link" referrerpolicy="unsafe-url">                   <svg>                     <use href="https://medx.b-cdn.net/tmpl/v6/img/svg/sprite.svg#logo_fb" x="0" y="0" />                   </svg>                 </a>                 <a href="https://sciencex.com/profile/sm-login-redirect/google/" class="login-link" referrerpolicy="unsafe-url">                   <svg>                     <use href="https://medx.b-cdn.net/tmpl/v6/img/svg/sprite.svg#logo_google" x="0" y="0" />                   </svg>                 </a>                 <a href="https://sciencex.com/profile/sm-login-redirect/apple/" class="login-link" referrerpolicy="unsafe-url">                   <svg>                     <use href="https://medx.b-cdn.net/tmpl/v6/img/svg/sprite.svg#logo_apple" x="0" y="0" />                   </svg>                 </a>               <br>                 <a href="https://sciencex.com/profile/pwdreset/">Forget Password?</a>               <br>                 <a class="font-weight-normal" href="https://sciencex.com/help/account/">Learn more</a>               <br>share this!<br>1<br>1<br>Share<br>Email<br>                                                         March 9, 2021                                                                                                              <br>                                           by Bay Area Lyme Foundation                                 <br>Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that five herbal medicines had potent activity compared to commonly-used antibiotics in test tubes against Babesia duncani, a malaria-like parasite found on the West Coast of the U.S. that causes the disease babesiosis.<br>Published in the journal <i>Frontiers in Cellular and Infection Microbiology</i>, the <a href="https://medicalxpress.com/tags/laboratory+study/" rel="tag" class="textTag">laboratory study</a> was funded in part by the Bay Area Lyme Foundation. Collaborating researchers were from Johns Hopkins Bloomberg School of Public Health, California Center for Functional Medicine, and FOCUS Health Group, Naturopathic.<br>"This research is particularly important as babesiosis is a significant emerging health risk. Due to limited therapeutics and a rise in <a href="https://medicalxpress.com/tags/treatment+resistance/" rel="tag" class="textTag">treatment resistance</a>, current treatment options for this <a href="https://medicalxpress.com/tags/disease/" rel="tag" class="textTag">disease</a> are inadequate and many patients rely on herbal therapies for which there is only anecdotal evidence of efficacy," said co-author Sunjya K. Schweig, MD, Founder and Director, California Center for Functional Medicine and Scientific Advisory Board Member, Bay Area Lyme Foundation, who has also studied herbal treatments for Lyme disease.<br>"Increasingly, Americans with chronic diseases are pursuing complementary and alternative <a href="https://medicalxpress.com/tags/medicine/" rel="tag" class="textTag">medicine</a> to improve general health or quality of life. We hope this data offers inspiration to other researchers to further explore similar options for people living with persistent tick-borne diseases that do not respond to current treatments," added Dr. Schweig.<br>While current treatment protocols for babesiosis recommend use of antibiotics including atovaquone, azithromycin, clindamycin, quinine, and their combinations, these regimens are often associated with treatment failures and significant side effects, even in immunocompetent patients. In addition, <a href="https://medicalxpress.com/tags/epidemiologic+studies/" rel="tag" class="textTag">epidemiologic studies</a> have documented that up to 23% of patients with babesiosis experienced concurrent Lyme disease and its associated disabling effects.<br>According to this laboratory study, the five <a href="https://medicalxpress.com/tags/herbal+medicines/" rel="tag" class="textTag">herbal medicines</a> that demonstrated inhibitory activity against B. duncani are:<br>Further, the study discovered that the <a href="https://medicalxpress.com/tags/bioactive+compounds/" rel="tag" class="textTag">bioactive compounds</a> derived from <i>Cryptolepis sanguinolenta</i>, <i>Artemisia annua</i>, and Scutellaria baicalensis, had comparable or even better activity against B. duncani than the commonly used antimicrobial medications quinine and clindamycin.<br>This is the first study to report the antibabesial activity of Scutellaria baicalensis. However, the antimicrobial and anti-inflammatory activity of <i>Alchornea cordifolia</i> and <i>Polygonum cuspidatum</i> extracts have been previously documented, and other studies have found benefits of combining agents such as compounds derived from <i>Cryptolepis sanguinolenta</i> and an artemisinin-based therapy.<br>These compounds still need to be tested both in vitro and in animal models as well as in <a href="https://medicalxpress.com/tags/clinical+trials/" rel="tag" class="textTag">clinical trials</a>. While each of these botanical medicines are already in clinical use, it is important for future studies to evaluate them directly in patients using specific clinical treatment regimens, as each have the potential to produce side effects in patients, and should be taken only under the care of a clinician knowledgeable of their capabilities and toxicities.<br>"Herbal medicines have been successfully used by various traditional medicine systems and ancient cultures," said Linda Giampa, executive director, Bay Area Lyme Foundation. "Coinfected tick-borne disease patients frequently experience a greater number of symptoms for a longer duration than those with Lyme disease alone, pointing to the need for novel treatments for babesiosis, one of the most common tick-borne infections after Lyme disease. We hope that findings from this study are an important step towards developing new therapeutic options for doctors and their patients with persistent Lyme disease and other tick-borne infections."<br><strong>More information:</strong>                                                     "Botanical medicines Cryptolepis sanguinolenta, Artemisia annua, Scutellaria baicalensis, Polygonum cuspidatum, and Alchornea cordifolia demonstrate inhibitory activity against Babesia duncani," <i>Frontiers in Cellular and Infection Microbiology</i>, 2021.                                                                                                                                                                                             <br>Explore further<br>Facebook<br>Twitter<br>Email<br> Feedback to editors<br>59 minutes ago<br><span>0</span><br>1 hour ago<br><span>0</span><br>21 hours ago<br><span>0</span><br>23 hours ago<br><span>0</span><br>Nov 8, 2025<br><span>1</span><br>59 minutes ago<br>1 hour ago<br>3 hours ago<br>3 hours ago<br>9 hours ago<br>13 hours ago<br>13 hours ago<br>13 hours ago<br>15 hours ago<br>15 hours ago<br>Feb 21, 2020<br>Dec 8, 2020<br>Dec 11, 2020<br>Jun 20, 2017<br>Aug 3, 2018<br>Jun 20, 2018<br>59 minutes ago<br>3 hours ago<br>21 hours ago<br>17 hours ago<br>19 hours ago<br>15 hours ago<br><br>                                 <small>                                 This summary was automatically generated using LLM.                                  <a class="text-info" href="https://sciencex.com/help/ai-disclaimer/" target="_blank">Full disclaimer</a>                                 </small>                             <br>                                          Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.                                            For general inquiries, please use our  <a href="https://sciencex.com/help/feedback/" target="_blank">contact form</a>.                                           For general feedback, use the public comments section below (please <a href="https://sciencex.com/help/comments/" target="_blank">adhere to guidelines</a>).                                         <br>Please select the most appropriate category to facilitate processing of your request<br>Thank you for taking time to provide your feedback to the editors.<br>Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. <br>                                             Your email address is used <strong>only</strong> to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose.                                            The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.                                          <br><br>                   Get weekly and/or daily updates delivered to your inbox.                    You can unsubscribe at any time and we'll never share your details to third parties.                <br>                    <a href="https://sciencex.com/help/newsletter/" class="popup-cookies-more pr-4" target="_blank">More information</a>                   <a href="https://sciencex.com/help/privacy/" class="popup-cookies-more" target="_blank">Privacy policy</a>              <br>                     We keep our content available to everyone.                     Consider supporting Science&nbsp;X's mission by getting a premium account.              <br>Daily science news on research developments and the latest scientific innovations<br>The latest engineering, electronics and technology advances<br> The most comprehensive sci-tech news coverage on the web<br><br><a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQbWdscmtvQi15MVJ3QU53T3dEalhrTWFJdnJKWmhmby1ybHJLU1hoNl9FRE1SZXA4VnExby1SS1hhSFpnT0x2LTRIMFg5LVI1c1lJWkZiUnhZdjlSd2dyakZPWVhRY255Ujk1b1EyU3poYXFZRUlMV0JqN2lSWmVOaTQwTDViYmljZ0tWQ3pmaw?oc=5">source</a>
Posted on by — Leave a comment

Pi Network Price Up 3% Today: Pi Core Team Releases Pi Node Version 0.5.4 Update! – Pintu

Jakarta, Pintu News – The price of Pi Network recorded a 3% increase today, November 10, 2025, as positive sentiment from the community increased following the release of the Pi Node version 0.5.4 update by the core development team, Pi Core Team.
This update brings a number of important improvements in Node performance, mining reward calculation, as well as user experience in the Pi Desktop app, which is considered a strategic step in strengthening the network infrastructure ahead of the next phase of development.
On November 10, 2025, the price of Pi Network was recorded at $0.2288, an increase of 3.7% in 24 hours. If converted to the current rupiah ($1 = IDR 16,651), then 1 Pi Network is IDR 3,809.
Within 24 hours, the price of PI moved within a range of $0.2204 to $0.2296, indicating moderate volatility in the day trading session. The market capitalization stands at $1.90 billion, while the fully diluted valuation stands at $2.93 billion.
Read also: Ripple Price Prediction: XRP Bearish Trend Strengthens, Will it Continue to Fall?
Currently, the trading volume in the last 24 hours stands at $22.87 million, indicating fairly active market participation.
Pi Network officially released the Pi Node version 0.5.4 update on November 7, 2025. In this update, the development team brings a number of significant improvements focused on Node performance, the accuracy of Node mining reward calculations, as well as improved user experience in the Pi Desktop app.
Pi Node version 0.5.4 has been released! This update introduces several improvements to Node performance, Node mining rewards calculations, and the user experience on the Pi Desktop application. https://t.co/jeozstvj2I
This latest version aims to strengthen the reliability and accessibility of the Node system, which is a critical component in the Pi Network ecosystem. With these improvements, Node users are expected to experience more stable and efficient performance, especially in the process of validating transactions and participating in network consensus.
This update reflects the Pi Network development team’s commitment to continuously developing a technical infrastructure that supports the adoption and decentralization of the network on an ongoing basis.
Read also: Bitcoin and Ethereum Surge, these 5 Altcoins Rise up to 50% Today
In a major transaction recorded on November 8, 2025, a total of 50,000,000 Pi tokens (equivalent to approximately $11 million) were moved from the Pi Foundation 11 wallet to Pi Foundation 2. This information was confirmed through successful transaction data on the block ledger 23563932, with a transaction fee of just 0.01 π.
BREAKING NEWS! ⚡

12 HOURS AGO
50,000,000 $Pi — YES, 50M Pi just moved between Pi Foundation wallets.
From Pi Foundation 11 to Pi Foundation 2.

Big moves. Silent execution.
The foundation is clearly preparing for the next major phase of Pi Network 🔥 pic.twitter.com/hRrBRFsxZr
This large transfer of funds is a quiet but structured move, signaling an internal strategic move by the Pi Foundation. While there has been no official announcement regarding the purpose of the transfer, these moves suggest that the core team is preparing for the next major phase in the development of the Pi Network ecosystem.
This move confirms the active internal dynamics behind the scenes, and could be part of the preparation towards the launch of new features, network expansion, or other strategic initiatives in Pi Network’s roadmap going forward.
That’s the latest information about crypto. Follow us on Google News to get the latest crypto news about crypto projects and blockchain technology. Also, learn crypto from scratch with complete discussion through Pintu Academy and stay up-to-date with the latest crypto market such as bitcoin price today, xrp coin price today, dogecoin and other crypto asset prices through Pintu Market.
Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app via Google Play Store or App Store now. Also, get a web trading experience with various advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro.
*Disclaimer
This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Crypto trading activities have high risk and volatility, always do your own research and use cold cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.

source

Posted on by — Leave a comment

XRP Price Prediction: Ripple Drags On! Noomez Coin ($NNZ) Presale Is the Clear Path to 100x Gains – Crypto Economy

Home – Crypto Presales – XRP Price Prediction: Ripple Drags On! Noomez Coin ($NNZ) Presale Is the Clear Path to 100x Gains
XRP price prediction is the question on every trader’s mind. XRP touched $2.48 with an 8.65% daily rise, but momentum still looks shaky.

Volume is high, yet the chart keeps stalling near intraday highs. Many are asking if the next real move will come from Ripple or somewhere new.
With Ripple’s story dragging and upside capped for now, attention is shifting to Noomez, an impressive fast-moving presale that’s winning early interest.
As pointed out, XRP trades at $2.48 with an 8.65% daily increase, but its movement still feels uncertain. The chart shows short bursts of green followed by quick pullbacks, suggesting resistance near the $2.50-$2.70 zone.
Market cap now sits above $149.15B, while trading volume exceeds $4.46B in 24 hours. Those numbers show activity, not conviction. Traders remain divided on where XRP heads next and if it can regain the pace seen in earlier rallies.
The outlook for Ripple depends on how long it can sustain investor patience. Its use cases in payments and remittances remain valid, but the lack of new catalysts is making many holders restless.
Price Prediction:
Analysts debating what is XRP price prediction 2025 agree that XRP can grow, but those tracking the latest XRP crypto price prediction see limited upside compared to faster-moving presale coins gaining serious traction.
Ripple’s steady progress in payments hasn’t translated into explosive token growth. XRP still carries the weight of long-running legal and regulatory battles, and that uncertainty keeps big investors on the sidelines.
While smaller traders continue speculating, most recognize that XRP’s momentum depends on factors beyond market sentiment, such as institutional adoption and cross-border transaction demand.
Even with steady on-chain volume, the pace of development feels slow compared to newer, faster-moving tokens. The lack of upcoming major updates or network shifts leaves little reason for traders to expect a sudden breakout.
Many now ask, could XRP hit $20? But reaching that kind of level would require a market-wide shift far greater than its current trajectory suggests. For now, XRP remains stable but uninspiring, prompting traders to rotate profits into more dynamic opportunities before the next market cycle accelerates.

While XRP struggles to excite traders, Noomez ($NNZ) is turning heads as its Stage 3 presale kicks into full gear at $0.0000151. The project’s momentum is undeniable.
Every stage lasts up to seven days, but with hundreds of new wallets joining daily, each one is selling out faster than expected. The next stage will bring another price increase, and with unsold tokens permanently burned at each close, scarcity keeps tightening.
The Noom Gauge lights up in real time to show progress, adding a sense of urgency that few presales ever achieve. Investors who joined early are already seeing growth before launch, and those entering now still sit near the ground floor of a 28-stage curve that ends at $0.0028.
With visible burns, transparent tracking, and clear token limits, the $NNZ coin is proving that timing matters, and right now is when conviction pays off.
What makes the Noomez token stand out isn’t just hype but structure. The presale has 28 transparent stages, each one burning leftover tokens at closing and lighting the Noom Gauge to track progress live.
With a total supply of 280 billion $NNZ and 50% allocated to presale, every completed stage reduces what’s left in circulation, making each token more valuable over time.
Beyond the presale, the foundation is built for long-term growth. Holders can stake $NNZ for 30 to 365 days after launch, earning rewards from a locked pool, while the Noom Engine sends partner tokens directly to wallets.
The liquidity will be locked, the team’s tokens vested for up to a year, and referral bonuses will reward early promoters instantly.
The impressive key features driving trader attention:
With each price step rising and supply shrinking, traders know $NNZ isn’t just another meme coin. It’s the moment to move before the next stage leaves them behind.
For More Information:
Website: Visit the Official Noomez Website 
Telegram: Join the Noomez Telegram Channel
Twitter: Follow Noomez ON X (Formerly Twitter)
This article contains information about a cryptocurrency presale. Crypto Economy is not associated with the project. As with any initiative within the crypto ecosystem, we encourage users to do their own research before participating, carefully considering both the potential and the risks involved. This content is for informational purposes only and does not constitute investment advice.
RELATED POSTS
Ads
Follow us on Social Networks
Crypto Tutorials
Crypto Reviews
Crypto Economy Newsletter
I accept the conditions and receive your newsletters.
© Crypto Economy
 Privacy Policy   |  Publication Policy
 Ethical Journalism Politic 
 Cookie Policy | Contest Rules | Partners | About us

source